1.Research advance in tumors associated with microphthalmia-associated transcription factor gene family.
Chinese Journal of Pathology 2011;40(7):496-498
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
;
genetics
;
metabolism
;
Carcinoma, Renal Cell
;
genetics
;
metabolism
;
Cell Cycle Proteins
;
genetics
;
metabolism
;
Humans
;
Melanoma
;
genetics
;
metabolism
;
Microphthalmia-Associated Transcription Factor
;
genetics
;
metabolism
;
Neoplasm Proteins
;
genetics
;
metabolism
;
Oncogene Proteins, Fusion
;
genetics
;
metabolism
;
Perivascular Epithelioid Cell Neoplasms
;
genetics
;
metabolism
;
Sarcoma, Clear Cell
;
genetics
;
metabolism
;
Translocation, Genetic
2.Lotus (Nelumbo nuficera) flower essential oil increased melanogenesis in normal human melanocytes.
Songhee JEON ; Nan Hyung KIM ; Byung Soo KOO ; Ji Young KIM ; Ai Young LEE
Experimental & Molecular Medicine 2009;41(7):517-524
In this study, the essential oil from lotus flower extract, including petals and stamens, was assessed with regard to its effects on melanogenesis in human melanocytes. The lotus flower essential oil was shown to stimulate melanin synthesis and tyrosinase activity in a dose-dependent manner. The lotus flower essential oil induced the expression of tyrosinase, microphthalmia-associated transcription factor M (MITF-M), and tyrosinase-related proten-2 (TRP-2) proteins, but not tyrosinase mRNA. Moreover, it increased the phosphorylation of ERK and cAMP response element binding protein (CREB). In order to verify the effective components of the lotus flower oil, its lipid composition was assessed. It was found to be comprised of palmitic acid methyl ester (22.66%), linoleic acid methyl ester (11.16%), palmitoleic acid methyl ester (7.55%) and linolenic acid methyl ester (5.16%). Among these components, palmitic acid methyl ester clearly induced melanogenesis as the result of increased tyrosinase expression, thereby indicating that it may play a role in the regulation of melanin content. Thus, our results indicate that lotus flower oil may prove useful in the development of gray hair prevention agents or tanning reagents.
Blotting, Western
;
Cell Proliferation
;
Cyclic AMP/metabolism
;
Cyclic AMP Response Element-Binding Protein/genetics/metabolism
;
Flowers/*chemistry
;
Gas Chromatography-Mass Spectrometry
;
Humans
;
Intramolecular Oxidoreductases/genetics/metabolism
;
Lotus/*chemistry
;
Melanins/*biosynthesis
;
Melanocytes/*drug effects/metabolism
;
Microphthalmia-Associated Transcription Factor/genetics/metabolism
;
Monophenol Monooxygenase/genetics/metabolism
;
Phosphorylation
;
Plant Oils/*pharmacology
;
RNA, Messenger/genetics/metabolism
;
Reverse Transcriptase Polymerase Chain Reaction
;
Skin/cytology/drug effects/metabolism
3.Analysis of nuclear localization and signal function of MITF protein predisposing to Warrdenburg syndrome.
Hua ZHANG ; Juan FENG ; Hongsheng CHEN ; Jiada LI ; Hunjin LUO ; Yong FENG
Chinese Journal of Medical Genetics 2015;32(6):805-809
OBJECTIVETo study the role of dysfunction of nuclear localization signals (NLS) of MITF protein in the pathogenesis of Waardenburg syndrome.
METHODSEukaryotic expression plasmid pCMV-MITF-Flag was used as a template to generate mutant plasmid pCMV-MITF△NLS-Flag by molecular cloning technique in order to design the mutagenic primers. The UACC903 cells were transfected transiently with MITF and MITF△NLS plasmids, and the luciferase activity assays were performed to determine their impact on the transcriptional activities of target gene tyrosinase (TYR). The oligonucleotide 5'-GAACGAAGAAGAAGATTT-3' was subcloned into pEGFP-N1 to generate recombinant eukaryotic expression plasmid pEGFP-N1-MITF-NLS. The NIH3T3 cells were transfected separately with MITF, MITF△NLS, pEGFP-N1 and pEGFP-N1-NLS plasmids, and their subcellular distribution was observed by immunoflorescence assays.
RESULTSExpression plasmids for the mutant MITF△NLS with loss of core NLS sequence and pEGFP-N1-NLS coupled with MITF△NLS were successfully generated. Compared with the wild-type MITF, MITF△NLS was not able to transactivate the transcriptional activities of promoter TYR and did not affect the normal function of MITF. MITF△NLS was only localized in the cytoplasm and pEGFP-N1 was found in both the cytoplasm and nucleus, whereas pEGFP-N1-NLS was mainly located in the nucleus.
CONCLUSIONThis study has confirmed the localization function of NLS sequence 213ERRRRF218 within the MITF protein. Mutant MITF with loss of NLS has failed to transactivate the transcriptional activities of target gene TYR, which can result in melanocyte defects and cause WS.
Amino Acid Sequence ; Animals ; Cell Line, Tumor ; Genetic Predisposition to Disease ; genetics ; Green Fluorescent Proteins ; genetics ; metabolism ; Humans ; Luciferases ; genetics ; metabolism ; Mice ; Microphthalmia-Associated Transcription Factor ; genetics ; metabolism ; Microscopy, Confocal ; Monophenol Monooxygenase ; genetics ; metabolism ; Mutation ; NIH 3T3 Cells ; Nuclear Localization Signals ; genetics ; Transcriptional Activation ; Transfection ; Waardenburg Syndrome ; diagnosis ; genetics ; metabolism
4.Bee venom stimulates human melanocyte proliferation, melanogenesis, dendricity and migration.
Songhee JEON ; Nan Hyung KIM ; Byung Soo KOO ; Hyun Joo LEE ; Ai Young LEE
Experimental & Molecular Medicine 2007;39(5):603-613
Pigmentation may result from melanocyte proliferation, melanogenesis, migration or increases in dendricity. Recently, it has been reported that secreted phospholipase A2(sPLA2) known as a component of bee venom (BV), stimulates melanocyte dendricity and pigmentation. BV has been used clinically to control rheumatoid arthritis and to ameliorate pain via its anti-inflammatory and antinociceptive properties. Moreover, after treatment with BV, pigmentation around the injection sites was occasionally observed and the pigmentation lasted a few months. However, no study has been done about the effect of BV on melanocytes. Thus, in the present study, we examined the effect of BV on the proliferation, melanogenesis, dendricity and migration in normal human melanocytes and its signal transduction. BV increased the number of melanocytes dose and time dependently through PKA, ERK, and PI3K/Akt activation. The level of cAMP was also increased by BV treatment. Moreover, BV induced melanogenesis through increased tyrosinase expression. Furthermore, BV induced melanocyte dendricity and migration through PLA2activation. Overall, in this study, we demonstrated that BV may have an effect on the melanocyte proliferation, melanogenesis, dendricity and migration through complex signaling pathways in vitro, responsible for the pigmentation. Thus, our study suggests a possibility that BV may be developed as a therapeutic drug for inducing repigmentation in vitiligo skin.
Animals
;
Base Sequence
;
Bee Venoms/*pharmacology
;
Cell Movement/drug effects
;
Cell Proliferation/drug effects
;
Cells, Cultured
;
Cyclic AMP/metabolism
;
DNA Primers/genetics
;
Forskolin/pharmacology
;
Gene Expression/drug effects
;
Humans
;
Melanins/biosynthesis
;
Melanocytes/cytology/*drug effects/physiology
;
Microphthalmia-Associated Transcription Factor/biosynthesis/genetics
;
Monophenol Monooxygenase/biosynthesis/genetics
;
Signal Transduction/drug effects
5.Effect of xanthohumol on melanogenesis in B16 melanoma cells.
Jeung Hyun KOO ; Hyoung Tae KIM ; Ha Yong YOON ; Kang Beom KWON ; Il Whan CHOI ; Sung Hoo JUNG ; Han Uk KIM ; Byung Hyun PARK ; Jin Woo PARK
Experimental & Molecular Medicine 2008;40(3):313-319
Xanthohumol (XH), the principal prenylflavonoid of the hop plant (Humulus lupulus L.), dose-dependently inhibited isobutylmethylxanthine (IBMX)-induced melanogenesis in B16 melanoma cells, with little cytotoxicity at the effective concentrations. Decreased melanin content was accompanied by reduced tyrosinase enzyme activity, protein and mRNA expression. The levels of tyrosinase-related protein 1 and 2 mRNAs were decreased by XH. XH also inhibited alpha-melanocyte stimulating hormone- or forskolin-induced increases in melanogenesis, suggesting an action on the cAMP-dependent melanogenic pathway. XH downregulated the protein and mRNA expression of microphthalmia-associated transcription factor (MITF), a master transcriptional regulator of key melanogenic enzymes. These results suggest that XH might act as a hypo-pigmenting agent through the downregulation of MITF in the cAMP-dependent melanogenic pathway.
1-Methyl-3-isobutylxanthine/pharmacology
;
Animals
;
Cell Line
;
Cell Survival/drug effects
;
Dose-Response Relationship, Drug
;
Down-Regulation
;
Drug Antagonism
;
Forskolin/pharmacology
;
*Humulus
;
Intramolecular Oxidoreductases/antagonists & inhibitors/biosynthesis
;
Melanins/antagonists & inhibitors/*biosynthesis
;
Melanocytes/*drug effects/*metabolism
;
Melanoma, Experimental
;
Membrane Glycoproteins/antagonists & inhibitors/biosynthesis
;
Mice
;
Microphthalmia-Associated Transcription Factor/antagonists & inhibitors
;
Monophenol Monooxygenase/antagonists & inhibitors/biosynthesis/genetics
;
Oxidoreductases/antagonists & inhibitors/biosynthesis
;
Propiophenones/*pharmacology
;
Signal Transduction/drug effects
;
alpha-MSH/metabolism